Liposarcoma (LPS) is a malignant tumor that belongs to the class of soft tissue sarcomas. Its most prevalent subtypes are well-differentiated (WD-) and dedifferentiated (DD-) LPS. These are distinguished by a shared cytogenetic feature, characterized by the amplification of the 12q13-15 region, which encompasses two oncogenes: MDM2 and CDK4. Professor Richter's research group demonstrated the presence of non-canonical DNA structures, known as G-quadruplexes (G4s), within the promoter of MDM2 and CDK4 in WD/DDLPS cells. In the context of WDLPS, XRCC6/Ku70 was identified as a human protein capable of specifically interacting with a subset of G4s, including one that had previously been identified within the CDK4 promoter. Hence, the Ku70-CDK4-G4 interaction has been the subject of extensive investigation both in vitro and in WDLPS cells, revealing its association with CDK4 promoter without DNA damage. Given the tight genomic association between WDLPS and DDLPS, the present study aimed to investigate whether the Ku70-G4 interaction also occurs in the more aggressive LPS subtype and to explore its potential functional role in the regulation of CDK4 expression. To this end, Ku70 and G4s localization was first evaluated in patient-derived DDLPS cell lines through immunofluorescence experiments, and direct Ku70-G4 interactions were quantified using Proximity Ligation Assay (PLA). This combined approach revealed that Ku70 directly interacts with a subset of G4s, with a number of interactions significantly higher in DDLPS cells compared to WDLPS. Furthermore, I explored the hypothesis that Ku70-G4 binding influences CDK4 transcription in WD/DDLPS cells. Upon silencing of Ku70 in WD/DDLPS with Ku70-targeted siRNAs, I observed decreased CDK4 expression in WDLPS cells, but not in DDLPS, suggesting that the regulatory mechanism underlying Ku70-mediated CDK4 transcription may differ between the two subtypes. Finally, to map at genome wide level the regions where Ku70 binds in association with G4s and DNA damage in DDLPS cell lines, I performed CUT&Tag experiments, successfully generating high-quality libraries ready for next-generation sequencing. This study provides a foundation for investigating the functional and potential therapeutic relevance of the Ku70–G4 interaction in WD/DDLPS.
Liposarcoma (LPS) is a malignant tumor that belongs to the class of soft tissue sarcomas. Its most prevalent subtypes are well-differentiated (WD-) and dedifferentiated (DD-) LPS. These are distinguished by a shared cytogenetic feature, characterized by the amplification of the 12q13-15 region, which encompasses two oncogenes: MDM2 and CDK4. Professor Richter's research group demonstrated the presence of non-canonical DNA structures, known as G-quadruplexes (G4s), within the promoter of MDM2 and CDK4 in WD/DDLPS cells. In the context of WDLPS, XRCC6/Ku70 was identified as a human protein capable of specifically interacting with a subset of G4s, including one that had previously been identified within the CDK4 promoter. Hence, the Ku70-CDK4-G4 interaction has been the subject of extensive investigation both in vitro and in WDLPS cells, revealing its association with CDK4 promoter without DNA damage. Given the tight genomic association between WDLPS and DDLPS, the present study aimed to investigate whether the Ku70-G4 interaction also occurs in the more aggressive LPS subtype and to explore its potential functional role in the regulation of CDK4 expression. To this end, Ku70 and G4s localization was first evaluated in patient-derived DDLPS cell lines through immunofluorescence experiments, and direct Ku70-G4 interactions were quantified using Proximity Ligation Assay (PLA). This combined approach revealed that Ku70 directly interacts with a subset of G4s, with a number of interactions significantly higher in DDLPS cells compared to WDLPS. Furthermore, I explored the hypothesis that Ku70-G4 binding influences CDK4 transcription in WD/DDLPS cells. Upon silencing of Ku70 in WD/DDLPS with Ku70-targeted siRNAs, I observed decreased CDK4 expression in WDLPS cells, but not in DDLPS, suggesting that the regulatory mechanism underlying Ku70-mediated CDK4 transcription may differ between the two subtypes. Finally, to map at genome wide level the regions where Ku70 binds in association with G4s and DNA damage in DDLPS cell lines, I performed CUT&Tag experiments, successfully generating high-quality libraries ready for next-generation sequencing. This study provides a foundation for investigating the functional and potential therapeutic relevance of the Ku70–G4 interaction in WD/DDLPS.
Investigation on the Functional role of Ku70 Binding to DNA G-Quadruplexes in Dedifferentiated Liposarcoma
MORELLI, MARTA
2025/2026
Abstract
Liposarcoma (LPS) is a malignant tumor that belongs to the class of soft tissue sarcomas. Its most prevalent subtypes are well-differentiated (WD-) and dedifferentiated (DD-) LPS. These are distinguished by a shared cytogenetic feature, characterized by the amplification of the 12q13-15 region, which encompasses two oncogenes: MDM2 and CDK4. Professor Richter's research group demonstrated the presence of non-canonical DNA structures, known as G-quadruplexes (G4s), within the promoter of MDM2 and CDK4 in WD/DDLPS cells. In the context of WDLPS, XRCC6/Ku70 was identified as a human protein capable of specifically interacting with a subset of G4s, including one that had previously been identified within the CDK4 promoter. Hence, the Ku70-CDK4-G4 interaction has been the subject of extensive investigation both in vitro and in WDLPS cells, revealing its association with CDK4 promoter without DNA damage. Given the tight genomic association between WDLPS and DDLPS, the present study aimed to investigate whether the Ku70-G4 interaction also occurs in the more aggressive LPS subtype and to explore its potential functional role in the regulation of CDK4 expression. To this end, Ku70 and G4s localization was first evaluated in patient-derived DDLPS cell lines through immunofluorescence experiments, and direct Ku70-G4 interactions were quantified using Proximity Ligation Assay (PLA). This combined approach revealed that Ku70 directly interacts with a subset of G4s, with a number of interactions significantly higher in DDLPS cells compared to WDLPS. Furthermore, I explored the hypothesis that Ku70-G4 binding influences CDK4 transcription in WD/DDLPS cells. Upon silencing of Ku70 in WD/DDLPS with Ku70-targeted siRNAs, I observed decreased CDK4 expression in WDLPS cells, but not in DDLPS, suggesting that the regulatory mechanism underlying Ku70-mediated CDK4 transcription may differ between the two subtypes. Finally, to map at genome wide level the regions where Ku70 binds in association with G4s and DNA damage in DDLPS cell lines, I performed CUT&Tag experiments, successfully generating high-quality libraries ready for next-generation sequencing. This study provides a foundation for investigating the functional and potential therapeutic relevance of the Ku70–G4 interaction in WD/DDLPS.| File | Dimensione | Formato | |
|---|---|---|---|
|
Morelli_Marta.pdf
Accesso riservato
Dimensione
6.78 MB
Formato
Adobe PDF
|
6.78 MB | Adobe PDF |
The text of this website © Università degli studi di Padova. Full Text are published under a non-exclusive license. Metadata are under a CC0 License
https://hdl.handle.net/20.500.12608/115440